GGrantIndex
← Leaderboards

Teresa Gomez-Isla

Massachusetts General Hospital

$19,324,052
Attributed
$19,324,052
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.8M · FY201325
$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,981,860 · 8

By mechanism

P30$17,488,258 · 3
P50$5,032,234 · 2
RF1$2,887,030 · 1
R01$2,116,271 · 1
P01$1,458,067 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseCognitiveDementiaAutopsyMassachusettsBrainDetectionImpaired CognitionPathologicMolecularNeuroimagingParticipantCohortElderlyFutureProgramsAmyloidSynapsesPositron-Emission TomographyImagePhenotypeTau ProteinsLink

Grant awards (30)

Massachusetts Alzheimer's Disease Research Center (MADRC)$4,825,067
P30 · FY2025 · AG · contact PI
Administrative Core$2,011,452
P30 · FY2025 · AG · contact PI
Massachusetts Alzheimer's Disease Research Center (MADRC)$4,832,741
P30 · FY2024 · AG · contact PI
Administrative Core$1,700,557
P30 · FY2024 · AG · contact PI
Clinical Core$808,599
P30 · FY2023 · AG · contact PI
Clinical Core$808,599
P30 · FY2022 · AG · contact PI
Clinical Core$840,069
P30 · FY2021 · AG · contact PI
Clinical Core$852,575
P30 · FY2020 · AG · contact PI
Postmortem validation of novel tau PET tracers$2,887,030
RF1 · FY2019 · AG · contact PI
Clinical Core$808,599
P30 · FY2019 · AG · contact PI
Project 2: Neuropathology of Amyloid and Tau$336,986
P01 · FY2019 · AG · contact PI
Core B - Clinical Core$782,117
P50 · FY2018 · AG · contact PI
Project 2: Neuropathology of Amyloid and Tau$275,603
P01 · FY2018 · AG · contact PI
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience$217,594
P50 · FY2018 · AG · contact PI
Core B - Clinical Core$832,933
P50 · FY2017 · AG · contact PI
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology$425,809
R01 · FY2017 · AG · contact PI
Project 2: Neuropathology of Amyloid and Tau$289,711
P01 · FY2017 · AG · contact PI
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience$231,732
P50 · FY2017 · AG · contact PI
Core B - Clinical Core$781,779
P50 · FY2016 · AG · contact PI
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology$425,809
R01 · FY2016 · AG · contact PI
Project 2: Neuropathology of Amyloid and Tau$269,832
P01 · FY2016 · AG · contact PI
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience$217,500
P50 · FY2016 · AG · contact PI
Core B - Clinical Core$758,327
P50 · FY2015 · AG · contact PI
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology$413,035
R01 · FY2015 · AG · contact PI
Project 2: Neuropathology of Amyloid and Tau$285,935
P01 · FY2015 · AG · contact PI
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience$210,973
P50 · FY2015 · AG · contact PI
Core B - Clinical Core$781,779
P50 · FY2014 · AG · contact PI
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology$425,809
R01 · FY2014 · AG · contact PI
Brain Amyloid Accrual in Non Demented People: Preclinical AD or Brain Resilience$217,500
P50 · FY2014 · AG · contact PI
Dissecting molecular mechanisms involved in resilience of Alzheimer's pathology$425,809
R01 · FY2013 · AG · contact PI